GoodRx (Nasdaq: GDRX) has teamed up with Novo Nordisk (NOV: N) to make all dose levels of Ozempic (semaglutide) and Wegovy ...

Vanda Pharmaceuticals (Nasdaq: VNDA) secured a sweeping victory in its legal battle with the US regulator after the Court of Appeals for the District of Columbia Circuit overturned the agency’s ...

Merck & Co (NYSE: MRK) and Daiichi Sankyo (TYO: 4568) have received Breakthrough Therapy designation from the US regulator ...

A clinical-stage specialty pharma company based in Tel Aviv, Israel, focused on developing needle-free, powder-based ...

Swedish biotech Anocca has raised about 440 million Swedish kronor ($46 million) in new financing to accelerate development ...

US pharma major Bristol Myers Squibb has appointed Dr Nathan Pennell as senior vice president, worldwide head of medical ...

The European Commission (EC) granted marketing authorization for Ogsiveo (nirogacestat), an oral gamma secretase inhibitor, ...

The bladder cancer market across the eight major markets (8MM: USA, France, Germany, Italy, Spain, UK, China, and Japan) is projected to grow from $3 billion in 2023 to $16 billion in 2033, at a ...

Boehringer Ingelheim and Palatin Technologies today announced a global research collaboration and licensing agreement aiming ...

Privately-held dermatology specialist LEO Pharma today revealed robust growth and significantly improved profitability, ...

Brazil’s Fiocruz, through the Drug Technology Institute (Farmanguinhos), and the pharmaceutical company EMS have signed two ...

Sweden’s Board for the Assessment of Pharmaceutical Information, NBL, has clarified the regulations for online advertising ...